Ftse Mib
34.492,41
0,13%
DAX
18.497,94
-0,09%
S&P 500
5.277,51
0,80%
NASDAQ
16.735,02
-0,01%
Bitcoin
67.720,06
0,35%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Novus Therapeutics Inc (NVUS) Novus Therapeutics Inc (NVUS) Notizie

NVUS

Novus Therapeutics (NVUS)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:NVUS
DataOraFonteTitoloSimboloCompagnia
22/06/202312:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NVUSNovus Therapeutics Inc
08/06/202322:05Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:NVUSNovus Therapeutics Inc
05/06/202312:04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:NVUSNovus Therapeutics Inc
22/05/202319:27Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:NVUSNovus Therapeutics Inc
18/05/202323:16Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:NVUSNovus Therapeutics Inc
11/05/202323:07Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:NVUSNovus Therapeutics Inc
03/05/202300:49Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NVUSNovus Therapeutics Inc
01/05/202322:53Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:NVUSNovus Therapeutics Inc
01/05/202322:49Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:NVUSNovus Therapeutics Inc
24/03/202222:05Edgar (US Regulatory)Annual Report (10-k)NASDAQ:NVUSNovus Therapeutics Inc
14/02/202221:01Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:NVUSNovus Therapeutics Inc
21/05/202123:04Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NASDAQ:NVUSNovus Therapeutics Inc
20/04/202113:00Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:NVUSNovus Therapeutics Inc
12/04/202112:04Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:NVUSNovus Therapeutics Inc
16/02/202122:43Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:NVUSNovus Therapeutics Inc
05/01/202122:39Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:NVUSNovus Therapeutics Inc
22/12/202022:50Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)NASDAQ:NVUSNovus Therapeutics Inc
13/11/202023:05Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)NASDAQ:NVUSNovus Therapeutics Inc
02/11/202014:00Business WireNovus Therapeutics Announces First Patient Enrolled in Phase 2a Clinical Trial of Anti-CD40L Antibody AT-1501 in Amyotrophic ...NASDAQ:NVUSNovus Therapeutics Inc
23/10/202023:17Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:NVUSNovus Therapeutics Inc
02/10/202017:00Business WireNovus Therapeutics Announces One-for-Eighteen Reverse Stock SplitNASDAQ:NVUSNovus Therapeutics Inc
15/09/202022:56Business WireNovus Therapeutics to Present at H.C. Wainwright and Cantor Global Investment ConferencesNASDAQ:NVUSNovus Therapeutics Inc
14/09/202022:31Business WireNovus Therapeutics Announces Acquisition of Anelixis TherapeuticsNASDAQ:NVUSNovus Therapeutics Inc
25/03/202021:07Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:NVUSNovus Therapeutics Inc
20/02/202012:12Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:NVUSNovus Therapeutics Inc
22/07/201912:00GlobeNewswire Inc.Adynxx Adds Gregory J. Flesher to Board of Directors, Completes Up-listing to OTCQB MarketNASDAQ:NVUSNovus Therapeutics Inc
01/05/201912:45Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:NVUSNovus Therapeutics Inc
30/04/201922:11Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:NVUSNovus Therapeutics Inc
07/09/201815:02Edgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:NVUSNovus Therapeutics Inc
04/09/201822:40Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:NVUSNovus Therapeutics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:NVUS

La tua Cronologia

BIT
UCG
Unicredit
BIT
TIT
Telecom Italia
BIT
ISP
Intesa Sanpaolo
BIT
STLAM
Stellantis NV
BIT
STMMI
ST Microelectronics
BIT
ENI
Eni
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
TITR
Telecom Italia
BIT
ENEL
Enel
BIT
TEN
Tenaris
BIT
BPE
Bper Banca
BIT
RACE
Ferrari NV
BIT
LDO
Leonardo
BIT
PIRC
Pirelli & C
BIT
SPM
Saipem
BIT
MONC
Moncler
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network